Market Overview

Hearing Ligand Pharma's Promacta Has Been Approved for the Treatment of HepC Patients with Low Blood Platelet Counts

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Rumors FDA

 

Related Articles (LGND)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters